×

Summit Therapeutics to Present at 15th Annual Needham Healthcare Conference

OXFORD, United Kingdom, April 06, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile infection, announces that Mr Glyn Edwards, Chief Executive Officer, will present at Needham & Company’s 15th Annual Healthcare Conference, 13 April 2016 at 11:20am EDT in New York City.

A live audio webcast of the presentation will be available through the Investors section on the Company’s website, www.summitplc.com. A replay of the webcast will be available soon after the live presentation.

About Summit Therapeutics
Summit is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease, Duchenne muscular dystrophy, and the infectious disease, Clostridium difficile infection. Further information is available at www.summitplc.com and Summit can be followed on Twitter (@summitplc).

For more information, please contact:

Summit
Glyn Edwards / Richard Pye (UK office)Tel: +44 (0)1235 443 951
Erik Ostrowski / Michelle Avery (US office)+1 617 225 4455
Cairn Financial Advisers LLP
(Nominated Adviser)
Liam Murray / Tony RawlinsonTel: +44 (0)20 77148 7900
N+1 Singer
(Broker)
Aubrey Powell / Jen BoorerTel: +44 (0)20 7496 3000
Peckwater PR
(Financial public relations, UK)Tel: +44 (0)7879 458 364
Tarquin Edwardstarquin.edwards@peckwaterpr.co.uk
MacDougall Biomedical Communications
(US media contact)Tel: +1 781 235 3060
Chris Erdmancerdman@macbiocom.com

-END-


Source:Summit Therapeutics PLC